I.SigNal

29/04/2022

Patients in or post COVID-19 infection

Study title:
1. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
2. COVID-19 and cardiac arrhythmias: A global perspective on arrhythmia characteristics and management strategies

Findings:
- It is recommended to take an ECG or other types of cardiac monitoring in the recovery phase to check abnormality in post COVID-19 infection
- Atrial fibrillation was the most commonly reported tachyarrhythmia whereas severe sinus bradycardia and complete heart block were the most common bradyarrhythmias
- For identifying COVID-19 related arrhythmic risk or cardiac injury, Cardea SOLO can be a useful tool

Read the full study here. :
1. https://www.sciencedirect.com/science/article/pii/S1547527120306251
2. https://link.springer.com/article/10.1007/s10840-020-00789-9

Background Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described. We sought to better understand the cardiac arrhythmic manifestations and treatment st...

22/04/2022

Clinical benefits of long-term monitoring

When it comes to the clinical evidence of the effect of the long-term ECG monitoring, there have been a lot of clinical articles and papers that compare continuous ECG patch with a standard holter to evaluate the clinical efficacy and usability, and the results show much better outcomes in continuous ECG patch monitoring for diagnostic yield of arrhythmias

Read the full study here. : https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1610370

08/04/2022

The clinical significance of perioperative AF in THA and TKA patients

Study title:
New-Onset Perioperative Atrial Fibrillation Is Associated with Increased All-Cause Mortality in Elderly Patients Undergoing Total Knee and Hip Replacements

Conclusion:
- One-year all-cause mortality in elderly patients undergoing TKA or THA is significantly increased in the patients that develop new postoperative AF
- These patients warrant increased clinical surveillance following surgery

Read the full study here. :
https://www.karger.com/Article/FullText/514482

* This content is provided for APAC healthcare professionals.

Introduction: Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are common surgeries performed in elderly patients with osteoarthritis. Limited data address the clinical significance of perioperative atrial fibrillation (AF) in these patients. This study aimed to determine whether preex...

01/04/2022

Risk factors that make your patient's heart in danger.
These are risk factors which cause cardiovascular disease!
If your patient has these risk factors, please check the heart rhythm with long-term ECG monitoring, Cardea SOLO.
⚠️ alcohols
⚠️ lack of excersice
⚠️ obesity
⚠️ ≥ 65 years of age

* This content is provided for APAC healthcare professionals.

18/03/2022

Why Cardea SOLO is efficient for arrythmia patients and healthcare professionals?

* This content is provided for APAC healthcare professionals.

11/03/2022

How to apply Cardea SOLO to patients? Here is a simple and useful video explains all about it! Please contact us if you have further inquries.

Watch video here: https://youtu.be/BihyVss2VFk
Visit our homepage with following link: http://isignal.co.kr/en/

* This content is provided for APAC healthcare professionals.

04/03/2022

How to diagnose AF and who needs opportunistic screening for AF?

According to the 2020 ESC guidelines,

AF should be diagnosed with
- Standard 12 lead ECG recording
- Single lead ECG tracing ≥ 30s

Opportunistic screening for AF is needed in
- Hypertensive patients
- Patients with OSA
- Patients ≥ 65 years of age

For more details, please check the ESC 2020 guidelines here: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management

ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Atrial Fibrillation. They should be essential in everyday clinical decision making.

25/02/2022

[Cardea SOLO] Here's the introduction for 7-day wearable ECG patch, Cardea SOLO. Visit our website to learn more about Cardea SOLO.

Watch video: https://youtu.be/vrqEt_6eWcI
Visit website: http://isignal.co.kr/en/

* This content is provided for APAC healthcare professionals.

What is Cardea SOLO? Learn about the 7-day ECG monitoring solution, Cardea SOLO.Visit our website for more information and product demo: www.isignal.co.kr ...

18/02/2022

Cardiovascular deaths related to AF are increasing, especially among younger adults according to Dr. Yoshihiro Tanaka's study.

Read the full study: https://www.ahajournals.org/doi/10.1161/JAHA.120.020163

* This content is provided for global HCPs including APAC cardiologists.

Background Prevalence of atrial fibrillation (AF) continues to increase and is associated with significant cardiovascular morbidity and mortality. To inform prevention strategies aimed at reducing ...

11/02/2022

New data published in the 'Journal of the American Heart Association' shows that patients who have ype 1 or type 2 diabetes and AFib are less likely to notice irregular heartbeat. The authors found that patients were about 25% less likely than people without diabetes to recognize common symptoms of Afib. Prakash Deedwania, immediate past chair of the American Heart Association Diabetes Committee, explains "keeping these new obsevations in mind, along with the serious consequences of failing to recognize AFib in time, it seems prudent to consider screening older patients with diabetes for AFib so that treatment may be initated when appropriate".

Read full article: https://www.cardiovascularbusiness.com/topics/heart-rhythm/remarkable-new-findings-suggest-patients-diabetes-should-be-screened-afib?utm_source=newsletter&utm_medium=cvb_news

Patients who have type 1 or type 2 diabetes and atrial fibrillation (AFib) are less likely to notice symptoms related to an irregular heartbeat, according to new data published in the Journal of the American Heart Association.

04/02/2022

Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey
Wearable single- or multiple-lead ECG technology is accepted for multiple indications in current clinical practice and triggers AF diagnosis and treatment.

Read more:https://www.escardio.org/static-file/Escardio/Subspecialty/EHRA/Surveys%20&%20Scientific%20Initiatives/Manninger%202021%20Europace%20Current%20perspectives%20on%20wearable%20rhythm%20recordings%20wEHRAbles2.pdf

28/01/2022

We are thrilled to introduce our official homepage. You can get the newest updates on i.SigNal and Cardea SOLO. Explanation of disease, comunity for Healthcare Providers, information on patnership and job openings are all available on our homepage.

Explore more: http://isignal.co.kr/en/

쉽게 받는 연속 심전도 검사 카디아솔로 의료진의 부정맥 진단을 보조하기 위한 패치형 홀터심전계인 카디아솔로로 쉽게 연속 심전도 검사를 받을 수 있습니다. 일반인용 의료진용 * 카디아솔로는 홀터심전계로서 장기간의 심....

21/01/2022

Atrial Fibrillation significantly increases a person’s risk of serious complications and death from COVID-19, Intermountain study finds

"Patients with atrial fibrillation are at higher risk than the general population for serious complications from COVID-19 illness.” said Michael J. Cutler, DO, PhD, the lead investigator of the study and a heart rhythm specialist at the Intermountain Healthcare Heart Institute.

Read full article here: https://stateofreform.com/featured/2021/11/intermountain-covid-study/

A new study finds that patients with atrial fibrillation are at significantly higher risk to experience serious complications from COVID-19.

14/01/2022

According to the published clinical study in the Journal of the American Heart Association, diabetic patients having atrial fibrillation less often perceive atrial fibrillation symptoms, although they have worse quality of life and more cardiac and neurological comorbidities than patients without diabetes.
This multicenter cohort study raises the question of whether patients with diabetes should be systematically screened for silent atrial fibrillation.

You can read the full study here:
https://www.ahajournals.org/doi/10.1161/JAHA.121.021800

Background Diabetes is a major risk factor for atrial fibrillation (AF). However, it remains unclear whether individual AF phenotype and related comorbidities differ between patients who have AF wi...

07/01/2022

Happy New Year!
All the best for you in 2022.

20/12/2021

If you have 2nd degree heart block, the electrical impulses will not reaqch the lower chambers of the heart. It can affect the flow of oxygen in the blood to your body and brain. An ECG form of 2nd degree AV block in which there is intermittent non-conducted P waves without progressive prolongation of the PR interval.
Before it develops into a complete heart block, you should get checked ASAP.

* This content is provided for APAC healthcare professionals.

17/12/2021

PVC is premature ventricular contractions. This is one of the most common cause of irregular heart rhythms. PVCs are difficult for physician to detect during routine physical check-ups, because the epsodes of PVCs are occasional.
If you experience prolonged PVCs, you should seek for a medical advice. Continuous long-term ECG monitoring with CardeaSolo will be super helpful to find underlying issues of PVC.

* This content is provided for APAC healthcare professionals.

10/12/2021

Atrial Flutter is closely related to Atrial Fibrillation. Common symptoms are rapid heartbeats, dizziness, shortness of breath, and tiredness.
Atrial Flutter develops a re-entry circuit within the atria' myocardium. It creates too much of electrical signals but still in a steady rhythm. When you have fast relatively regular heartbeats, don't lose the golden time.

* This content is provided for APAC healthcare professionals.

03/12/2021

Have you ever felt "irregular quick" heart beats? Do you also feel fatigue, dizziness, or shotness of breath? These can imply you might have atrial fibrillation. If it is AFib, it raises the chances for a stroke and other heart complications.

Especially, people who are older than 60 are more likely to get AFib than others. Our product, Cardea SOLO certified by FDA is one of the most innovative wearble ECG device.

* This content is provided for APAC healthcare professionals.

26/11/2021

Early studies suggest that COVID-19 is associated with a high incidence of cardiac arrhythmias. Severe acute respiratory syndrome with coronavirus infection may cause injury to cardiac myocytes and increase arrhythmia risk.

* This content is provided for APAC healthcare professionals.
https://www.britishcardiovascularsociety.org/resources/editorials/articles/covid-19-cardiac-arrhythmias

For more information,
https://www.heartrhythmjournal.com/article/S1547-5271(20)30594-4/fulltext

We use cookies to improve your experience on our site. For information on these cookies and how to remove them, read our privacy policy.

19/11/2021

Why early detection of AF is important?
Let's see AF-related major outcomes.

- 5 times increased stroke rate
- 1.5-3.5 folds increase of death
- LV dysfunction/HF in 20~30% of AF patients
- Impaired quality of life in > 60% of patients

* This content is provided for APAC healthcare professionals.

https://academic.oup.com/eurheartj/article/42/5/373/5899003

For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the Guidelines see European

12/11/2021

Cardea SOLO is utilized as an effective ECG monitoring tool for various clinical trials such as WHISH STAR study which is led by the Stanford University and funded by the U.S. National Institution.

Find more details at
https://grantome.com/grant/NIH/R01-HL136390-01

Atrial fibrillation (AF) is the most common arrhythmia in older women and results in a higher risk of stroke, death and other comorbidities. Current treatments for AF are limited and novel preventive...

05/11/2021

How long would it take for the Cardea Solo product to analyze and make the ECG summary report?

It only takes 5 minutes!

Cardea SOLO's software provides you with the summary report within 5 minutes.
Also, you can review the whole raw data through the software.
Don't waste your time to diagnose. Don't let your patient wait too long.

* This content is provided for APAC healthcare professionals.

29/10/2021

What kind of arrhythmias can be detected by Cardea SOLO?

- Atrial Flutter/Fibrillation
- Ventricular Tachycardia
- Pause
- Heart Block
- Supraventricular Tachycardia
- Premature Atrial/Ventricular Contractions
- Bradycardia/ Tachycardia

22/10/2021

Risk factors that make your patient's heart in danger.

These are risk factors which cause cardiovascular disease!
If your patient has these risk factors, please check the heart rhythm with long-term ECG monitoring, Cardea SOLO.

⚠️ alcohols
⚠️ lack of excersice
⚠️ obesity
⚠️ ≥ 65 years of age

15/10/2021

Symptoms that your patient's heart is in danger.

If your patient mentioned any of the following symptoms, please check their heart rhythms.
Long-term ECG monitoring, Cardea SOLO, also helps detect the arrhythmia.

* This content is provided for APAC healthcare professionals.

08/10/2021

How to diagnose AF and who needs opportunistic screening for AF?

According to the 2020 ESC guidelines,

AF should be diagnosed with
- Standard 12 lead ECG recording
- Single lead ECG tracing ≥ 30s

Opportunistic screening for AF is needed in
- Hypertensive patients
- Patients with OSA
- Patients ≥ 65 years of age

For more details, please check the ESC 2020 guidelines.
https://academic.oup.com/eurheartj/article/42/5/373/5899003 #303292601

For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the Guidelines see European

29/09/2021

Today is the World Heart Day!💓

For the 520 million people are living with cardiovascular disease.

We hope most people find out arrhythmia on time with an innovative long-term ECG monitoring device, Cardea SOLO. ✊

https://world-heart-federation.org/world-heart-day/about-whd/

THE WORLD’S, AND THE WORLD HEART FEDERATION’S, BIGGEST AWARENESS-RAISING PLATFORM FOR CVD World Heart Day is celebrated every year on 29 September.

28/09/2021

[Congress] i.SigNal participated in THRS 2021! Visit our virtual booth and learn more about Cardea SOLO!

https://livetour.istaging.com/260c9a69-7209-4f7a-874b-592a6f21b937?index=1

* This content is provided for APAC healthcare professionals.

【i.SigNal by DREAMTECH】 i.SigNal was founded in 2019 by DREAMTECH as a new dedicated brand and organization for digital healthcare business, delivering both innovation and high quality throughout the whole value chain from R&D and product development to global commercialization and distribution....

20/09/2021

Happy Chuseok Holiday!

Chuseok, Korean Thanks Givingday is just around the corner and we wish everyone a wonderful holiday with family and loved ones. :)